中华皮肤科杂志
中華皮膚科雜誌
중화피부과잡지
Chinese Journal of Dermatology
2011年
4期
285-287
,共3页
袁晋%吴文育%宋萌萌%傅雯雯
袁晉%吳文育%宋萌萌%傅雯雯
원진%오문육%송맹맹%부문문
目的 比较复方倍他米松注射液和醋酸曲安奈德注射液皮损内注射治疗活动期斑秃的临床疗效.方法 将160例活动期斑秃患者随机分成两组,治疗组100例、对照组60例,治疗组用复方倍他米松注射液皮损内注射,对照组用醋酸曲安奈德注射液皮损内注射,每3周1次,12周后观察结果.结果 治疗12周后治疗组痊愈60例(60.0%),显效32例(32.0%),总有效率92.0%;对照组痊愈25例(41.7%),显效19例(31.67%),总有效率73.3%;治疗组有效率和痊愈率显著高于对照组(χ2值分别为10.25和5.06,P<0.01和<0.05).治疗组出现局部头皮萎缩8例(8%),局部毛囊炎8例(8%);对照组出现局部头皮萎缩9例(15%),局部毛囊炎3例(5%),两组不良反应发生率比较,差异无统计学意义(P>0.05).结论 复方倍他米松注射液皮损内注射治疗活动期斑秃疗效显著.
目的 比較複方倍他米鬆註射液和醋痠麯安奈德註射液皮損內註射治療活動期斑禿的臨床療效.方法 將160例活動期斑禿患者隨機分成兩組,治療組100例、對照組60例,治療組用複方倍他米鬆註射液皮損內註射,對照組用醋痠麯安奈德註射液皮損內註射,每3週1次,12週後觀察結果.結果 治療12週後治療組痊愈60例(60.0%),顯效32例(32.0%),總有效率92.0%;對照組痊愈25例(41.7%),顯效19例(31.67%),總有效率73.3%;治療組有效率和痊愈率顯著高于對照組(χ2值分彆為10.25和5.06,P<0.01和<0.05).治療組齣現跼部頭皮萎縮8例(8%),跼部毛囊炎8例(8%);對照組齣現跼部頭皮萎縮9例(15%),跼部毛囊炎3例(5%),兩組不良反應髮生率比較,差異無統計學意義(P>0.05).結論 複方倍他米鬆註射液皮損內註射治療活動期斑禿療效顯著.
목적 비교복방배타미송주사액화작산곡안내덕주사액피손내주사치료활동기반독적림상료효.방법 장160례활동기반독환자수궤분성량조,치료조100례、대조조60례,치료조용복방배타미송주사액피손내주사,대조조용작산곡안내덕주사액피손내주사,매3주1차,12주후관찰결과.결과 치료12주후치료조전유60례(60.0%),현효32례(32.0%),총유효솔92.0%;대조조전유25례(41.7%),현효19례(31.67%),총유효솔73.3%;치료조유효솔화전유솔현저고우대조조(χ2치분별위10.25화5.06,P<0.01화<0.05).치료조출현국부두피위축8례(8%),국부모낭염8례(8%);대조조출현국부두피위축9례(15%),국부모낭염3례(5%),량조불량반응발생솔비교,차이무통계학의의(P>0.05).결론 복방배타미송주사액피손내주사치료활동기반독료효현저.
Objective To compare the clinical efficacy of intralesional betamethasone versus triamcinolone acetonide acetate in the treatment of active alopecia areata. Methods A total of 160 patients with active alopecia areata were divided into two groups, test group (n = 100) treated with intralesional betamethasone, and control group (n = 60) treated with intralesional triamcinolone acetonide. Both injections were given once every 3 weeks for 12 consecutive weeks. Results After 12-week treatment, the cure rate, response rate, and total response rate were 60.0%, 32.0% and 92.0% in the test group, respectively, compared to 41.7%, 31.67% and 73.3% in the control group, respectively. A significant increase was observed in the cure rate and response rate in the test group compared with the control group (χ2 = 10.25, 5.06, P < 0.01 and 0.05). During the treatment course, 8 (8%) patients in the test group and 9 (15%) patients in the control group developed localized atrophy of the scalp; 8 (8%) patients in the test group and 3 (5%) patients in the control group developed localized folliculitis; no significant difference was observed between the two groups in the occurrence of adverse reactions (P> 0.05). Conclusion Intralesional use of compound betamethasone injection has a notable therapeutic effect on alopecia areata.